![Mark Timney](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark Timney
Algemeen Directeur bij
Attralus, Inc.
Profiel
Momenteel is Mark Timney voorzitter bij Blade Therapeutics, Inc. en Chief Executive Officer & Director bij The Medicines Co. De heer Timney zit ook in de raad van bestuur van Biotechnology Innovation Organization, Pharmaceutical Research & Manufacturers of America en Sarissa Capital Acquisition Corp. In zijn vorige loopbaan was de heer Timney President & Chief Executive Officer bij Purdue Pharma LP, President-Global Primary Care bij Merck & Co, Inc. en Chief Executive Officer & Director bij The Medicines Co. Mark Timney behaalde een bachelorgraad aan de Universiteit van Northumbria.
Actieve functies van Mark Timney
| Bedrijven | Functie | Begin |
|---|---|---|
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Directeur/Bestuurslid | - |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America BiotechnologyHealth Technology Provides pharmaceutical research and biotechnology services | Directeur/Bestuurslid | - |
Blade Therapeutics, Inc.
 Blade Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that focuses on developing treatments for fibrotic and neurodegenerative diseases | Voorzitter | 01-08-2020 |
Attralus, Inc.
 Attralus, Inc. Pharmaceuticals: MajorHealth Technology Develops novel pan-amyloid removal therapeutics | Algemeen Directeur | 10-05-2021 |
Anfield Road LLC | Algemeen Directeur | 01-01-2017 |
Eerdere bekende functies van Mark Timney
| Bedrijven | Functie | Einde |
|---|---|---|
| SARISSA CAPITAL ACQUISITION CORP. | Directeur/Bestuurslid | 13-04-2023 |
| THE MEDICINES COMPANY | Algemeen Directeur | 01-01-2020 |
Purdue Pharma LP
 Purdue Pharma LP Medical DistributorsDistribution Services Distributes medicines | Algemeen Directeur | 23-06-2017 |
| MERCK & CO., INC. | Corporate Officer/Principal | 01-07-2014 |
Opleiding van Mark Timney
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
90
Eerstegraads connecties
10
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 10 |
|---|---|
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
The Medicines Co.
 The Medicines Co. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops drugs for acute cardiovascular care | Health Technology |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
Purdue Pharma LP
Purdue Pharma LP Medical DistributorsDistribution Services Distributes medicines | Distribution Services |
University of Northumbria
 University of Northumbria Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pharmaceutical Research & Manufacturers of America
Pharmaceutical Research & Manufacturers of America BiotechnologyHealth Technology Provides pharmaceutical research and biotechnology services | Health Technology |
Blade Therapeutics, Inc.
Blade Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that focuses on developing treatments for fibrotic and neurodegenerative diseases | Health Technology |
Attralus, Inc.
Attralus, Inc. Pharmaceuticals: MajorHealth Technology Develops novel pan-amyloid removal therapeutics | Health Technology |
Sarissa Capital Acquisition Corp.
 Sarissa Capital Acquisition Corp. Financial ConglomeratesFinance Operates as blank check company | Finance |
Anfield Road LLC |
Kies MarketScreener 
